Product Code: GVR-4-68039-698-0
Companion Animal Medicine Market Growth & Trends:
The global companion animal medicine market size is expected to reach USD 41.18 billion by 2030 and is expected to expand at 9.9% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. The key factors driving the growth of the market for companion animal medicine include the rising pet population, the increased prevalence of diseases, and the availability of pet insurance.
In Canada for example, more than half of the country's households (around 60% of households) owned at least one dog or cat in 2022, according to the Canadian Animal Health Institute (CAHI). The country's dog population increased from 7.7 million in 2020 to 7.9 million in 2022, whereas the cat population increased from 8.1 million in 2020 to 8.5 million in 2022. CAHI also reported a surge in feline vet visits following the start of the COVID-19 outbreak in 2020.
The COVID-19 pandemic notably affected the market for companion animal medicine. The impact included dampened sales, supply chain challenges, operational hurdles, falling inpatient visits, and reduced demand. Elanco for instance reported a 20% decline in revenue during Q2 2020. The company's companion animal segment, in particular, was adversely impacted by the fall in brands in international markets and those administered in the clinic e.g. vaccines.
The company reported a recovery in sales during H2 2020. Vetoquinol on the other hand reported an increase in sales, driven by its essential portfolio including veterinary drugs in 2020 despite limited access to vet clinics and hospitals due to lockdown protocols. Boehringer Ingelheim too registered increased sales in the companion animal segment.
With the rising number of pets across the globe, the trend of pet humanization has gained traction in several key markets. Pet guardians are becoming increasingly aware of their pet's health, treatment, and well-being. This has increased the adoption of pet insurance to reduce the financial risks for them. Petplan- the largest pet insurance provider in the U.K. offers insurance policies for various species including dogs, cats, horses, small mammals, birds, reptiles, rabbits, and multi-pet owners. These policies provide coverage for physical and online consultations, prescription medicine, diagnostic tests, surgery, dental injury, cancer treatment, and more.
The rising prevalence of diseases in pets is another key driver expected to contribute to market growth. Parasitic infections from internal and external parasites for example, commonly affect pets. Antibiotics and topical therapies are often prescribed in the case of pyoderma. However, further testing and routine bathing with medicated shampoos may be prescribed in case of chronic or recurring pyoderma. For example, Viv Silky Shampoo by Vivaldis is indicated for various fungal and bacterial infections including superficial and deep pyoderma.
Companion Animal Medicine Market Report Highlights:
- The companion animal medicine industry was valued at USD 19.51 billion in 2022. It is further projected to grow at a CAGR of 9.9% during the forecast period
- Growing R&D initiatives by major companies are estimated to be a key driver for the market. Pet humanization is further contributing to increased expenditure on pets including pet medicines
- According to APPA, U.S. citizens spent about USD 34.3 billion on vet care and products in 2021. The category included expenditure on routine veterinary care, surgical procedures, and pharmaceuticals
- Based on animal type, the dog segment dominated the market with nearly 45% revenue share in 2022 owing to the large preference for dogs as pets and the rising prevalence of canine diseases
- The hospital pharmacy segment dominated the market by distribution channel in 2022. The factors contributing to the large share include higher patient footfalls at hospitals and the convenience of buying the necessary medications as soon as the pet is diagnosed
- North America region dominated the market in 2022 and registered the largest revenue share of over 36%. This is due to the region's high per capita animal healthcare spending and a large number of pet owners
- In Asia Pacific, the market is expected to grow at the fastest rate of over 10.4% CAGR due to the rising pet population and pet health awareness
Table of Contents
Chapter 1 Methodology and Scope
- 1.1 Market Segmentation and Scope
- 1.1.1 Segment scope
- 1.1.2 Regional scope
- 1.1.3 Estimates and forecast timeline
- 1.2 Research Methodology
- 1.3 Information procurement
- 1.3.1 Purchased database
- 1.3.2 GVR's internal database
- 1.3.3 Secondary sources
- 1.3.4 Primary research
- 1.3.5 Details of primary research
- 1.4 Information or Data Analysis
- 1.4.1 Data analysis models
- 1.5 Market Formulation & Validation
- 1.6 Model Details
- 1.7 List of Secondary Sources
- 1.8 Objectives
Chapter 2 Executive Summary
- 2.1 Companion Animal Medicine Market Summary
Chapter 3 Companion Animal Medicine Market Variables, Trends & Scope
- 3.1 Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Penetration & Growth Prospect Mapping, 2022
- 3.3 Companion Animal Medicine Market Dynamics
- 3.3.1 Market driver analysis
- 3.3.2 Market restraint analysis
- 3.3.3. Market opportunity analysis
- 3.3.4. Market challenge analysis
- 3.4 Companion Animal Medicine Market Analysis Tools: Porter's Five Forces
- 3.4.1 Supplier Power
- 3.4.2. Buyer Power
- 3.4.3. Substitution Threat
- 3.4.4. Threat of New Entrants
- 3.4.5. Competitive Rivalry
- 3.5 Companion Animal Medicine Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
- 3.5.1 Political/Legal Landscape
- 3.5.2 Economic Landscape
- 3.5.3 Social Landscape
- 3.5.4 Technology Landscape
- 3.6. Regulatory Landscape
- 3.7. Disease Prevalence Analysis
- 3.8. Pet population by species, by key countries
- 3.9. Pricing Analysis
- 3.10. Product Pipeline
Chapter 4 COVID-19 Impact Analysis
- 4.1 COVID-19 Prevalence Analysis
- 4.2. Current impact and future scenario
- 4.3. Impact on Market Players
Chapter 5 Companion Animal Medicine Market: Segment Analysis, By Animal Type, 2018 - 2030 (USD Million)
- 5.1 Animal Type Market Share Analysis, 2022&2030
- 5.2 Companion Animal Medicine market, by Animal Type, 2018 to 2030
- 5.3 Dogs
- 5.3.1 Dogs market, 2018 - 2030 (USD Million)
- 5.3.2 Biologics
- 5.3.2.1 Biologics market, 2018 - 2030 (USD Million)
- 5.3.2.2 Vaccines
- 5.3.2.2.1 Vaccines market, 2018 - 2030 (USD Million)
- 5.3.2.2.2 Attenuated Live Vaccines
- 5.3.2.2.2.1 Attenuated Live Vaccines market, 2018 - 2030 (USD Million)
- 5.3.2.2.3 Inactivated Vaccines
- 5.3.2.2.3.1 Inactivated Vaccines market, 2018 - 2030 (USD Million)
- 5.3.2.2.4 Recombinant Vaccines
- 5.3.2.2.4.1 Recombinant Vaccines market, 2018 - 2030 (USD Million)
- 5.3.2.2.5 Toxoid
- 5.3.2.2.5.1 Toxoid market, 2018 - 2030 (USD Million)
- 5.3.2.2.6 Other Vaccines
- 5.3.2.2.6.1 Other Vaccines market, 2018 - 2030 (USD Million)
- 5.3.2.2.7 Distemper
- 5.3.2.2.7.1 Distemper market, 2018 - 2030 (USD Million)
- 5.3.2.2.8 Kennel cough (Parainfluenza)
- 5.3.2.2.8.1 Kennel cough (Parainfluenza) market, 2018 - 2030 (USD Million)
- 5.3.2.2.9 Parvovirus
- 5.3.2.2.9.1 Parvovirus market, 2018 - 2030 (USD Million)
- 5.3.2.2.10 Canine herpes
- 5.3.2.2.10.1 Canine herpes market, 2018 - 2030 (USD Million)
- 5.3.2.2.11 Lyme Disease
- 5.3.2.2.11.1 Lyme Disease market, 2018 - 2030 (USD Million)
- 5.3.2.2.12 Rabies
- 5.3.2.2.12.1 Rabies market, 2018 - 2030 (USD Million)
- 5.3.2.3 Other biologics
- 5.3.2.3.1 Other biologics market, 2018 - 2030 (USD Million)
- 5.3.3 Pharmaceuticals
- 5.3.3.1 Pharmaceuticals market, 2018 - 2030 (USD Million)
- 5.3.3.2 Parasiticides
- 5.3.3.2.1 Parasiticides market, 2018 - 2030 (USD Million)
- 5.3.3.3 Anti-infectives
- 5.3.3.3.1 Anti-infectives market, 2018 - 2030 (USD Million)
- 5.3.3.4 Anti-inflammatory
- 5.3.3.4.1 Anti-inflammatory market, 2018 - 2030 (USD Million)
- 5.3.3.5 Analgesics
- 5.3.3.5.1 Analgesics market, 2018 - 2030 (USD Million)
- 5.3.3.6 Other Pharmaceuticals
- 5.3.3.6.1 Other Pharmaceuticals market, 2018 - 2030 (USD Million)
- 5.3.4 Medicated Feed Additives
- 5.3.4.1 Medicated Feed Additives market, 2018 - 2030 (USD Million)
- 5.3.5 Indication
- 5.3.5.1 Indication market, 2018 - 2030 (USD Million)
- 5.3.5.2 Infectious Diseases
- 5.3.5.2.1 Infectious Diseases market, 2018 - 2030 (USD Million)
- 5.3.5.3 Dermatologic Diseases
- 5.3.5.3.1 Dermatologic Diseases market, 2018 - 2030 (USD Million)
- 5.3.5.4 Pain
- 5.3.5.4.1 Pain market, 2018 - 2030 (USD Million)
- 5.3.5.5 Orthopedic Diseases
- 5.3.5.5.1 Orthopedic Diseases market, 2018 - 2030 (USD Million)
- 5.3.5.6 Behavioral Diseases
- 5.3.5.6.1 Behavioral Diseases market, 2018 - 2030 (USD Million)
- 5.3.5.7 Other Indications
- 5.3.5.7.1 Other Indications market, 2018 - 2030 (USD Million)
- 5.3.6 Distribution Channel
- 5.3.6.1 Distribution Channel market, 2018 - 2030 (USD Million)
- 5.3.6.2 Retail
- 5.3.6.2.1 Retail market, 2018 - 2030 (USD Million)
- 5.3.6.3 E-Commerce
- 5.3.6.3.1 E-Commerce market, 2018 - 2030 (USD Million)
- 5.3.6.4 Hospital Pharmacy
- 5.3.6.4.1 Hospital Pharmacy market, 2018 - 2030 (USD Million)
- 5.4 Cats
- 5.4.1 Cats market, 2018 - 2030 (USD Million)
- 5.4.2 Biologics
- 5.4.2.1 Biologics market, 2018 - 2030 (USD Million)
- 5.4.2.2 Vaccines
- 5.4.2.2.1 Vaccines market, 2018 - 2030 (USD Million)
- 5.4.2.2.2 Attenuated Live Vaccines
- 5.4.2.2.2.1 Attenuated Live Vaccines market, 2018 - 2030 (USD Million)
- 5.4.2.2.3 Inactivated Vaccines
- 5.4.2.2.3.1 Inactivated Vaccines market, 2018 - 2030 (USD Million)
- 5.4.2.2.4 Recombinant Vaccines
- 5.4.2.2.4.1 Recombinant Vaccines market, 2018 - 2030 (USD Million)
- 5.4.2.2.5 Toxoid
- 5.4.2.2.5.1 Toxoid market, 2018 - 2030 (USD Million)
- 5.4.2.2.6 Other Vaccines
- 5.4.2.2.6.1 Other Vaccines market, 2018 - 2030 (USD Million)
- 5.4.2.2.7 Rhinotracheitis
- 5.4.2.2.7.1 Rhinotracheitis market, 2018 - 2030 (USD Million)
- 5.4.2.2.8 Calicivirus
- 5.4.2.2.8.1 Calicivirus market, 2018 - 2030 (USD Million)
- 5.4.2.2.9 Coronavirus
- 5.4.2.2.9.1 Coronavirus market, 2018 - 2030 (USD Million)
- 5.4.2.2.10 Panleukopenia
- 5.4.2.2.10.1 Panleukopenia market, 2018 - 2030 (USD Million)
- 5.4.2.2.11 Rabies
- 5.4.2.2.11.1 Rabies market, 2018 - 2030 (USD Million)
- 5.4.2.3 Other biologics
- 5.4.2.3.1 Other biologics market, 2018 - 2030 (USD Million)
- 5.4.3 Pharmaceuticals
- 5.4.3.1 Pharmaceuticals market, 2018 - 2030 (USD Million)
- 5.4.3.2 Parasiticides
- 5.4.3.2.1 Parasiticides market, 2018 - 2030 (USD Million)
- 5.4.3.3 Anti-infectives
- 5.4.3.3.1 Anti-infectives market, 2018 - 2030 (USD Million)
- 5.4.3.4 Anti-inflammatory
- 5.4.3.4.1 Anti-inflammatory market, 2018 - 2030 (USD Million)
- 5.4.3.5 Analgesics
- 5.4.3.5.1 Analgesics market, 2018 - 2030 (USD Million)
- 5.4.3.6 Other Pharmaceuticals
- 5.4.3.6.1 Other Pharmaceuticals market, 2018 - 2030 (USD Million)
- 5.4.4 Medicated Feed Additives
- 5.4.4.1 Medicated Feed Additives market, 2018 - 2030 (USD Million)
- 5.4.5 Indication
- 5.4.5.1 Indication market, 2018 - 2030 (USD Million)
- 5.4.5.2 Infectious Diseases
- 5.4.5.2.1 Infectious Diseases market, 2018 - 2030 (USD Million)
- 5.4.5.3 Dermatologic Diseases
- 5.4.5.3.1 Dermatologic Diseases market, 2018 - 2030 (USD Million)
- 5.4.5.4 Pain
- 5.4.5.4.1 Pain market, 2018 - 2030 (USD Million)
- 5.4.5.5 Orthopedic Diseases
- 5.4.5.5.1 Orthopedic Diseases market, 2018 - 2030 (USD Million)
- 5.4.5.6 Behavioral Diseases
- 5.4.5.6.1 Behavioral Diseases market, 2018 - 2030 (USD Million)
- 5.4.5.7 Other Indications
- 5.4.5.7.1 Other Indications market, 2018 - 2030 (USD Million)
- 5.4.6 Distribution Channel
- 5.4.6.1 Distribution Channel market, 2018 - 2030 (USD Million)
- 5.4.6.2 Retail
- 5.4.6.2.1 Retail market, 2018 - 2030 (USD Million)
- 5.4.6.3 E-Commerce
- 5.4.6.3.1 E-Commerce market, 2018 - 2030 (USD Million)
- 5.4.6.4 Hospital Pharmacy
- 5.4.6.4.1 Hospital Pharmacy market, 2018 - 2030 (USD Million)
- 5.5 Horses
- 5.5.1 Horses market, 2018 - 2030 (USD Million)
- 5.5.2 Biologics
- 5.5.2.1 Biologics market, 2018 - 2030 (USD Million)
- 5.5.2.2 Vaccines
- 5.5.2.2.1 Vaccines market, 2018 - 2030 (USD Million)
- 5.5.2.2.2 Attenuated Live Vaccines
- 5.5.2.2.2.1 Attenuated Live Vaccines market, 2018 - 2030 (USD Million)
- 5.5.2.2.3 Inactivated Vaccines
- 5.5.2.2.3.1 Inactivated Vaccines market, 2018 - 2030 (USD Million)
- 5.5.2.2.4 Recombinant Vaccines
- 5.5.2.2.4.1 Recombinant Vaccines market, 2018 - 2030 (USD Million)
- 5.5.2.2.5 Toxoid
- 5.5.2.2.5.1 Toxoid market, 2018 - 2030 (USD Million)
- 5.5.2.2.6 Other Vaccines
- 5.5.2.2.6.1 Other Vaccines market, 2018 - 2030 (USD Million)
- 5.5.2.3 Other biologics
- 5.5.2.3.1 Other biologics market, 2018 - 2030 (USD Million)
- 5.5.3 Pharmaceuticals
- 5.5.3.1 Pharmaceuticals market, 2018 - 2030 (USD Million)
- 5.5.3.2 Parasiticides
- 5.5.3.2.1 Parasiticides market, 2018 - 2030 (USD Million)
- 5.5.3.3 Anti-infectives
- 5.5.3.3.1 Anti-infectives market, 2018 - 2030 (USD Million)
- 5.5.3.4 Anti-inflammatory
- 5.5.3.4.1 Anti-inflammatory market, 2018 - 2030 (USD Million)
- 5.5.3.5 Analgesics
- 5.5.3.5.1 Analgesics market, 2018 - 2030 (USD Million)
- 5.5.3.6 Other Pharmaceuticals
- 5.5.3.6.1 Other Pharmaceuticals market, 2018 - 2030 (USD Million)
- 5.5.4 Medicated Feed Additives
- 5.5.4.1 Medicated Feed Additives market, 2018 - 2030 (USD Million)
- 5.5.5 Indication
- 5.5.5.1 Indication market, 2018 - 2030 (USD Million)
- 5.5.5.2 Infectious Diseases
- 5.5.5.2.1 Infectious Diseases market, 2018 - 2030 (USD Million)
- 5.5.5.3 Dermatologic Diseases
- 5.5.5.3.1 Dermatologic Diseases market, 2018 - 2030 (USD Million)
- 5.5.5.4 Pain
- 5.5.5.4.1 Pain market, 2018 - 2030 (USD Million)
- 5.5.5.5 Orthopedic Diseases
- 5.5.5.5.1 Orthopedic Diseases market, 2018 - 2030 (USD Million)
- 5.5.5.6 Behavioral Diseases
- 5.5.5.6.1 Behavioral Diseases market, 2018 - 2030 (USD Million)
- 5.5.5.7 Other Indications
- 5.5.5.7.1 Other Indications market, 2018 - 2030 (USD Million)
- 5.5.6 Distribution Channel
- 5.5.6.1 Distribution Channel market, 2018 - 2030 (USD Million)
- 5.5.6.2 Retail
- 5.5.6.2.1 Retail market, 2018 - 2030 (USD Million)
- 5.5.6.3 E-Commerce
- 5.5.6.3.1 E-Commerce market, 2018 - 2030 (USD Million)
- 5.5.6.4 Hospital Pharmacy
- 5.5.6.4.1 Hospital Pharmacy market, 2018 - 2030 (USD Million)
- 5.6 Other companion animals
- 5.6.1 Other companion animals market, 2018 - 2030 (USD Million)
- 5.6.2 Biologics
- 5.6.2.1 Biologics market, 2018 - 2030 (USD Million)
- 5.6.2.2 Vaccines
- 5.6.2.2.1 Vaccines market, 2018 - 2030 (USD Million)
- 5.6.2.2.2 Attenuated Live Vaccines
- 5.6.2.2.2.1 Attenuated Live Vaccines market, 2018 - 2030 (USD Million)
- 5.6.2.2.3 Inactivated Vaccines
- 5.6.2.2.3.1 Inactivated Vaccines market, 2018 - 2030 (USD Million)
- 5.6.2.2.4 Recombinant Vaccines
- 5.6.2.2.4.1 Recombinant Vaccines market, 2018 - 2030 (USD Million)
- 5.6.2.2.5 Toxoid
- 5.6.2.2.5.1 Toxoid market, 2018 - 2030 (USD Million)
- 5.6.2.2.6 Other Vaccines
- 5.6.2.2.6.1 Other Vaccines market, 2018 - 2030 (USD Million)
- 5.6.2.3 Other biologics
- 5.6.2.3.1 Other biologics market, 2018 - 2030 (USD Million)
- 5.6.3 Pharmaceuticals
- 5.6.3.1 Pharmaceuticals market, 2018 - 2030 (USD Million)
- 5.6.3.2 Parasiticides
- 5.6.3.2.1 Parasiticides market, 2018 - 2030 (USD Million)
- 5.6.3.3 Anti-infectives
- 5.6.3.3.1 Anti-infectives market, 2018 - 2030 (USD Million)
- 5.6.3.4 Anti-inflammatory
- 5.6.3.4.1 Anti-inflammatory market, 2018 - 2030 (USD Million)
- 5.6.3.5 Analgesics
- 5.6.3.5.1 Analgesics market, 2018 - 2030 (USD Million)
- 5.6.3.6 Other Pharmaceuticals
- 5.6.3.6.1 Other Pharmaceuticals market, 2018 - 2030 (USD Million)
- 5.6.4 Medicated Feed Additives
- 5.6.4.1 Medicated Feed Additives market, 2018 - 2030 (USD Million)
- 5.6.5 Indication
- 5.6.5.1 Indication market, 2018 - 2030 (USD Million)
- 5.6.5.2 Infectious Diseases
- 5.6.5.2.1 Infectious Diseases market, 2018 - 2030 (USD Million)
- 5.6.5.3 Dermatologic Diseases
- 5.6.5.3.1 Dermatologic Diseases market, 2018 - 2030 (USD Million)
- 5.6.5.4 Pain
- 5.6.5.4.1 Pain market, 2018 - 2030 (USD Million)
- 5.6.5.5 Orthopedic Diseases
- 5.6.5.5.1 Orthopedic Diseases market, 2018 - 2030 (USD Million)
- 5.6.5.6 Behavioral Diseases
- 5.6.5.6.1 Behavioral Diseases market, 2018 - 2030 (USD Million)
- 5.6.5.7 Other Indications
- 5.6.5.7.1 Other Indications market, 2018 - 2030 (USD Million)
- 5.6.6 Distribution Channel
- 5.6.6.1 Distribution Channel market, 2018 - 2030 (USD Million)
- 5.6.6.2 Retail
- 5.6.6.2.1 Retail market, 2018 - 2030 (USD Million)
- 5.6.6.3 E-Commerce
- 5.6.6.3.1 E-Commerce market, 2018 - 2030 (USD Million)
- 5.6.6.4 Hospital Pharmacy
- 5.6.6.4.1 Hospital Pharmacy market, 2018 - 2030 (USD Million)
Chapter 6 Companion Animal Medicine Market: Regional Market Analysis 2018 - 2030 (USD Million)
- 6.1 Definition & Scope
- 6.2 Regional Movement Analysis, 2022&2030
- 6.3 Regional Market Snapshot
- 6.4 North America
- 6.4.1 North America Companion Animal Medicine Market, 2018 - 2030 (USD Million)
- 6.4.2. U.S.
- 6.4.2.1 U.S. Companion Animal Medicine Market, 2018 - 2030 (USD Million)
- 6.4.3 Canada
- 6.4.3.1 Canada Companion Animal Medicine Market, 2018 - 2030 (USD Million)
- 6.5 Europe
- 6.5.1 Europe Companion Animal Medicine Market, 2018 - 2030 (USD Million)
- 6.5.2 U.K.
- 6.5.2.1 U.K. Companion Animal Medicine Market, 2018 - 2030 (USD Million)
- 6.5.3 Germany
- 6.5.3.1 Germany Companion Animal Medicine Market, 2018 - 2030 (USD Million)
- 6.5.4 France
- 6.5.4.1 France Companion Animal Medicine Market, 2018 - 2030 (USD Million)
- 6.5.5 Italy
- 6.5.5.1 Italy Companion Animal Medicine Market, 2018 - 2030 (USD Million)
- 6.5.6 Spain
- 6.5.6.1 Spain Companion Animal Medicine Market, 2018 - 2030 (USD Million)
- 6.5.7 Russia
- 6.5.7.1 Russia Companion Animal Medicine Market, 2018 - 2030 (USD Million)
- 6.5.8 Rest of Europe
- 6.5.8.1 Rest of Europe Companion Animal Medicine Market, 2018 - 2030 (USD Million)
- 6.6 Asia Pacific
- 6.6.1 Asia Pacific Companion Animal Medicine market, 2018 - 2030 (USD Million)
- 6.6.2 Japan
- 6.6.2.1 Japan Companion Animal Medicine Market, 2018 - 2030 (USD Million)
- 6.6.3 China
- 6.6.3.1 China Companion Animal Medicine Market, 2018 - 2030 (USD million)
- 6.6.4 India
- 6.6.4.1 India Companion Animal Medicine Market, 2018 - 2030 (USD Million)
- 6.6.5 Rest of APAC
- 6.6.5.1 Rest of APAC Companion Animal Medicine Market, 2018 - 2030 (USD Million)
- 6.7 Latin America
- 6.7.1 Latin America Companion Animal Medicine Market, 2018 - 2030 (USD Million)
- 6.7.2 Brazil
- 6.7.2.1 Brazil Companion Animal Medicine Market, 2018 - 2030 (USD Million)
- 6.7.3 Mexico
- 6.7.3.1 Mexico Companion Animal Medicine Market, 2018 - 2030 (USD Million)
- 6.7.4 Argentina
- 6.7.4.1 Argentina Companion Animal Medicine Market, 2018 - 2030 (USD Million)
- 6.7.5 Rest of LATAM
- 6.7.5.1 Rest of LATAM Companion Animal Medicine Market, 2018 - 2030 (USD Million)
- 6.8 MEA
- 6.8.1 MEA Companion Animal Medicine Market, 2018 - 2030 (USD Million)
- 6.8.2 South Africa
- 6.8.2.1 South Africa Companion Animal Medicine Market, 2018 - 2030 (USD Million)
- 6.8.3 Saudi Arabia
- 6.8.3.1 Saudi Arabia Companion Animal Medicine Market, 2018 - 2030 (USD Million)
- 6.8.4 Rest of MEA
- 6.8.4.1 Rest of MEA Companion Animal Medicine Market, 2018 - 2030 (USD Million)
Chapter 7 Companion Animal Medicine Market - Competitive Analysis
- 7.1 Participant's Overview
- 7.2 Financial Performance
- 7.3 Product Benchmarking
- 7.4 Market Participant Categorization
- 7.5. Company Market Share Analysis
- 7.6. Strategy Mapping
- 7.6.1. Market Leaders
- 7.6.2. Innovators
- 7.7. List of Key Companies
Chapter 8 Companion Animal Medicine Market - Company Profiles
- 8.1 Merck & Co., Inc.
- 8.1.1 Company overview
- 8.1.2 Financial performance
- 8.1.3 Product benchmarking
- 8.1.4 Strategic initiatives
- 8.2 Ceva
- 8.2.1 Company overview
- 8.2.2 Financial performance
- 8.2.3 Product benchmarking
- 8.2.4 Strategic initiatives
- 8.3 Vetoquinol S.A.
- 8.3.1 Company overview
- 8.3.2 Financial performance
- 8.3.3 Product benchmarking
- 8.3.4 Strategic initiatives
- 8.4 Zoetis
- 8.4.1 Company overview
- 8.4.2 Financial performance
- 8.4.3 Product benchmarking
- 8.4.4 Strategic initiatives
- 8.5 Boehringer Ingelheim International GmbH
- 8.5.1 Company overview
- 8.5.2 Financial performance
- 8.5.3 Product benchmarking
- 8.5.4 Strategic initiatives
- 8.6 Elanco
- 8.6.1 Company overview
- 8.6.2 Financial performance
- 8.6.3 Product benchmarking
- 8.6.4 Strategic initiatives
- 8.7 Virbac
- 8.7.1 Company overview
- 8.7.2 Financial performance
- 8.7.3 Product benchmarking
- 8.7.4 Strategic initiatives
- 8.8 Bimeda, Inc.
- 8.8.1 Company overview
- 8.8.2 Financial performance
- 8.8.3 Product benchmarking
- 8.8.4 Strategic initiatives
- 8.9 Norbrook
- 8.9.1 Company overview
- 8.9.2 Financial performance
- 8.9.3 Product benchmarking
- 8.9.4 Strategic initiatives
- 8.10 Calier
- 8.10.1 Company overview
- 8.10.2 Financial performance
- 8.10.3 Product benchmarking
- 8.10.4 Strategic initiatives